Journal
CLINICAL AND VACCINE IMMUNOLOGY
Volume 21, Issue 5, Pages 777-782Publisher
AMER SOC MICROBIOLOGY
DOI: 10.1128/CVI.00003-14
Keywords
-
Categories
Funding
- National Institutes of Health [T32 AI055429]
- NIH [5R43AI91078, AI098774]
- NIH/OD [OD-011104-51]
Ask authors/readers for more resources
Recent incidents in the United States and abroad have heightened concerns about the use of ricin toxin as a bioterrorism agent. In this study, we produced, using a robust plant-based platform, four chimeric toxin-neutralizing monoclonal antibodies that were then evaluated for the ability to passively protect mice from a lethal-dose ricin challenge. The most effective antibody, c-PB10, was further evaluated in mice as a therapeutic following ricin exposure by injection and inhalation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available